drugset / Trial / NCT02214680

The Effect of Topical Treatment With Combigan Compared to Timolol and Brimonidine on Pupil Diameter

NCT02214680

Phase 2 Unknown 25 enrolled Carmel Medical Center
NaSingle-groupOpen-label

Summary

In this study we will explore the combined effect of Brimonidine and Timolol 0.5% (Combigan) eye drops on pupil dilation. It is a well studied phenoma that Brimonidine and a miotic effect on the pupil, however the combined effect of alpha agonist and beta blocker has not been studied.

Timeline

Start
2015-10
Primary completion
2016-08
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Brimonidine Small molecule Topical
Subject Timolol Other / unclassified 0.5 % Topical

Indications

No indication recorded.